Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (228)

2025

  1. Impact of mechanical circulatory support on outcomes in Takotsubo syndrome complicated by cardiogenic shock: Insights from the RETAKO registry

    International Journal of Cardiology, Vol. 419

2024

  1. A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 756-767

  2. Corrigendum to ‘Forecasting the Risk of Heart Failure Hospitalization After Acute Coronary Syndromes: the CORALYS HF Score’ [American Journal of Cardiology 206 (2023) 320-329, (S000291492300766X), (10.1016/j.amjcard.2023.08.010)]

    American Journal of Cardiology

  3. Cross-Validation of Risk Scores for Patients Undergoing Transcatheter Edge-to-Edge Repair for Mitral Regurgitation

    Journal of the Society for Cardiovascular Angiography and Interventions, Vol. 3, Núm. 2

  4. Efficacy and safety and efficacy of bempedoic acid in acute coronary syndrome. Design of the clinical trial ES-BempeDACS

    Revista Espanola de Cardiologia

  5. Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

    Journal of Clinical Medicine, Vol. 13, Núm. 9

  6. Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry

    International Journal of Cardiology, Vol. 397

  7. Impact of gender in patients with device-related thrombosis after left atrial appendage closure – A sub-analysis from the multicenter EUROC-DRT-registry

    Echocardiography, Vol. 41, Núm. 8

  8. Outcomes and predictors of left ventricle recovery in patients with severe left ventricular dysfunction undergoing transcatheter aortic valve implantation

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 20, Núm. 8, pp. e487-e495

  9. Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 34, Núm. 1, pp. 90-97

  10. Patterns for optimizing post-acute myocardial infarction antiplatelet treatment

    REC: CardioClinics, Vol. 59, Núm. 3, pp. 201-211

  11. Peripartum Takotsubo Cardiomyopathy: A Review and Insights from a National Registry

    Journal of Cardiovascular Development and Disease, Vol. 11, Núm. 2

  12. Prevalence and prognostic significance of malnutrition in patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair

    Catheterization and Cardiovascular Interventions, Vol. 104, Núm. 2, pp. 390-400

  13. Prognostic impact of shock in patients with type A acute aortic syndrome. Results of a nationwide multicenter study

    Hellenic Journal of Cardiology

  14. Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial

    Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460

  15. Renal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohort

    International Journal of Cardiology, Vol. 405

  16. Surgical vs Transcatheter Treatment in Patients With Coronary Artery Disease and Severe Aortic Stenosis

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 21, pp. 2472-2485

  17. Therapeutic management of CNIC polypill at discharge from a first acute coronary syndrome in Spain: The PANDORA study

    REC: CardioClinics, Vol. 59, Núm. 4, pp. 266-277

  18. Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annulus: A Randomized Clinical Trial

    Circulation, Vol. 149, Núm. 9, pp. 644-655

2023

  1. Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 1, pp. 77-87